MedTrace Logo

A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

NCT06837246 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 422

Last updated 2025-04-15

No results posted yet for this study

Summary

This is a double-blind, randomized, 12-week parallel study that aims to determine the effects of a cognitive nutritional supplement for 12 weeks on cognition parameters specific to attention/focus related domains, compared to a placebo control, in a general population of adult men and women in the United States.

Conditions

  • Cognition
  • Concentration
  • Attention
  • Focus

Interventions

DIETARY_SUPPLEMENT

Cognitive Nutritional Supplement

Pills of cognitive nutritional supplement

OTHER

Placebo

Matching placebo to active

Sponsors & Collaborators

  • Balchem Corporation

    collaborator INDUSTRY

  • Biofortis, Inc. (a Mérieux NutriSciences company)

    collaborator UNKNOWN

  • Pharmavite LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-24
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06837246 on ClinicalTrials.gov